Drug Eluting Stent Market Growth Outlook, Opportunities and Forecast 2026

Global Drug Eluting Stent Industry Outlook

According to the current analysis of Reports and Data, the global drug eluting stent market was valued at USD 5.63 Billion in 2018 and is expected to reach USD 8.74 Billion by year 2026, at a CAGR of 5.67 %. The study covers in-depth analysis of drug eluting stents and its extensive use in the cardiovascular diseases. Drug eluting stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Drug eluting stents are usually preferred over bare metal stents for most people. Drug eluting stents are generally to keep the blockage from recurring compared to bare metal stents. One of the major objectives of drug eluting stents is to limit neointimal hyperplasia. The global drug eluting stent market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries. However, strict regulatory approval process and lack of skilled professionals are major hindrance for the growth of global drug eluting market during 2019-2026. Conversely, the emerging markets of Asia-Pacific and Latin America are anticipated to provide lucrative growth opportunities to the market players involved in the global drug eluting stent market.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. The report clearly depicts the current global economic landscape and the considerable situation of the healthcare industry. A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research & development activities, and new drug pipelines are among the key factors that have driven the global pharma & healthcare industry growth in the recent past. Growing acceptance of telehealth and telemedicine services, rise in government initiatives for COVID-19 vaccine development, and escalating demand for advanced point-of-care diagnostics and home healthcare products have further bolstered the industry growth.

Further key findings from the report suggest

• Drug eluting stents are coated with medication that is slowly released to prevent the growth of scar tissue in the artery lining. Thus, the artery remains smooth, open, ensuring good blood flow.
• There are three key components to a drug eluting stent – the metal stent structure also called the stent platform which is generally made up of surgical stainless steel or a cobalt chromium alloy; these all contain nickel. The polymer which coats the metal stent: this coating contains the drug and delivers(elutes) it to the arterial wall over a period of time. The drug itself which suppresses the formation of excess tissue, sometimes known as “scar tissue”.
• There are two major types of polymer-based coatings included in the drug eluting stent market such as biodegradable and non-biodegradable polymer. Microporous surface, microstructured surface, slotted tubular surface, and nanoporous surface are types of polymer free coating
• Polymer coating can be conformal, inhibiting smooth cell proliferation over the entire surface of the stent, or abluminal, i.e. the release of the drug only has an effect on the surface in contact with the vessel wall
• On the basis of coating, polymer free coating stents segment in the global drug eluting stent market is anticipated to dominate the global drug eluting stents due to higher drug loading capacity of nanoporous surfaces, quicker drug eluting rate. Inflammatory issues caused by the polymers used in stents can be avoided by eliminating the polymer coating completely and releasing the antiproliferative drug directly from the stent surface
• On the basis of applications, coronary artery disease is expected to be the largest segment in the global drug eluting stents because of rise in the circulation of c reactive proteins, binge drinking and smoking
• Asia Pacific is projected to be the fastest growing segment in the global drug eluting market due to better medical facilities, government funding large population, increasing patient awareness, continuous improvement in healthcare facilities. In India, after the price capping by the central Government, the cost of drug eluting stents has come down to rupees thirty thousand.
• North America is anticipated to have the largest share (42%) in the global drug eluting market due to increasing prevalence of artery diseases, strict regulatory guidelines for medical device manufacturing and approval related to the commercial availability of the products.
• The benefits such as availability of surgery specialists, reduced hospital stay duration, and less charge of surgery have made ambulatory surgical centers the ideal option for the treatment which has made them the major segment among end-users during the forecast period in the global drug eluting stent market.

In-depth Study of the Competitive Landscape:

The global Drug Eluting Stent market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers & acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence.

Top companies profiled in the report include:

Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation

Key Market Regions Covered in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Drug Eluting Stent Market, by Coating (Revenue, USD Million; 2016–2026)

• Polymer based coating
• Biodegradable
• Non-biodegradable
• Polymer free coating
• Microporous Surface
• Microstructured Surface
• Slotted Tubular Surface
• Nanoporous Surface

Drug Eluting Stent Market, by Application (Revenue, USD Million; 2016–2026)

• Coronary Artery Disease
• Peripheral Artery Disease

Research Objective

• To provide a comprehensive analysis of the Drug Eluting Stent Industry, thereby providing a detailed structure of the market.
• To provide detailed insights into factors driving and restraining the growth of the Drug Eluting Stent Industry.
• To estimate the market size of each market segment which in turn is responsible for revenue generation of the respective countries.
  To provide strategic profiling of key companies present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market
• To identify business opportunities in the Drug Eluting Stent Market
• To provide a country-wise market forecast for market segments and sub-segments.

Request a Sample Report on Drug Eluting Stent Market @ https://www.reportsanddata.com/sample-enquiry-form/1786 

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.